Driving Innovation in Vaccine Research and Development
At BioNet, our Research and Development (R&D) efforts are at the forefront of vaccine innovation, combining cutting-edge science with a mission to address urgent public health challenges. Our R&D focuses on creating next-generation vaccines using advanced platforms, including recombinant, DNA, and mRNA technologies.
Advancing New Technology Platforms
Recombinant Vaccines
Recombinant vaccines have been shown safe and effective. BioNet used recombinant technology to produce a pertussis vaccine containing a genetically-inactivated pertussis toxin.
DNA Vaccines
Leveraging its expertise in recombinant DNA technology, BioNet also developed DNA vaccines against SARS-CoV-2.
mRNA Vaccines
BioNet has been developing genetically-designed vaccines using its proprietary “plug-and-play” design and production process enabling the rapid GMP production of mRNA vaccines.
Targeting
Global Health
Threats
BioNet’s development pipeline focuses on vaccines against respiratory diseases, vector-borne illnesses, and zoonotic infections, with a strong emphasis on re-emerging and pandemic threats. By addressing these critical areas, we aim to deliver innovative vaccines that improve global health outcomes.
Proprietary pertussis vaccine technology
Patents for our technology have been granted in many countries including the USA. We have been collaborating with partners to expand our pipeline of recombinant vaccines.
Proprietary mRNA Platform
Our clinically-proven mRNA plug-and-play platform enables the rapid development of a wide range of vaccines candidates. We have been collaborating with vaccine developers including academic partners to produce mRNA vaccines in our GMP facilities to advance local and global projects from research up to clinical trial stages.
Committed to Transforming Global Health
At BioNet, we believe that innovation is the key to a healthier, safer world. Our R&D teams work tirelessly to bring groundbreaking vaccine solutions to market, ensuring access to life-saving immunizations for all.